WO1998042739A3 - Proteines secretees et polynucleotides les codant - Google Patents

Proteines secretees et polynucleotides les codant Download PDF

Info

Publication number
WO1998042739A3
WO1998042739A3 PCT/US1998/005653 US9805653W WO9842739A3 WO 1998042739 A3 WO1998042739 A3 WO 1998042739A3 US 9805653 W US9805653 W US 9805653W WO 9842739 A3 WO9842739 A3 WO 9842739A3
Authority
WO
WIPO (PCT)
Prior art keywords
polynucleotides encoding
secreted proteins
polynucleotides
proteins
secreted
Prior art date
Application number
PCT/US1998/005653
Other languages
English (en)
Other versions
WO1998042739A2 (fr
Inventor
Kenneth Jacobs
John M Mccoy
Edward R Lavallie
Lisa A Racie
David Merberg
Maurice Treacy
Vikki Spaulding
Michael J Agostino
Original Assignee
Genetics Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genetics Inst filed Critical Genetics Inst
Priority to AU65783/98A priority Critical patent/AU6578398A/en
Priority to EP98911944A priority patent/EP0970111A2/fr
Priority to JP54587498A priority patent/JP2002503955A/ja
Priority to CA002283631A priority patent/CA2283631A1/fr
Publication of WO1998042739A2 publication Critical patent/WO1998042739A2/fr
Publication of WO1998042739A3 publication Critical patent/WO1998042739A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Reproductive Health (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Neurosurgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hematology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)

Abstract

La présente invention concerne des polynucléotides et les protéines codées par les polynucléotides de l'invention.
PCT/US1998/005653 1997-03-21 1998-03-20 Proteines secretees et polynucleotides les codant WO1998042739A2 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
AU65783/98A AU6578398A (en) 1997-03-21 1998-03-20 Secreted proteins and polynucleotides encoding them
EP98911944A EP0970111A2 (fr) 1997-03-21 1998-03-20 Proteines secretees et polynucleotides les codant
JP54587498A JP2002503955A (ja) 1997-03-21 1998-03-20 分泌蛋白およびそれらをコードするポリヌクレオチド
CA002283631A CA2283631A1 (fr) 1997-03-21 1998-03-20 Proteines secretees et polynucleotides les codant

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US82216797A 1997-03-21 1997-03-21
US08/822,167 1997-03-21
US4446698A 1998-03-19 1998-03-19
US09/044,466 1998-03-19

Publications (2)

Publication Number Publication Date
WO1998042739A2 WO1998042739A2 (fr) 1998-10-01
WO1998042739A3 true WO1998042739A3 (fr) 1998-12-03

Family

ID=26721594

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1998/005653 WO1998042739A2 (fr) 1997-03-21 1998-03-20 Proteines secretees et polynucleotides les codant

Country Status (5)

Country Link
EP (1) EP0970111A2 (fr)
JP (1) JP2002503955A (fr)
AU (1) AU6578398A (fr)
CA (1) CA2283631A1 (fr)
WO (1) WO1998042739A2 (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999014241A2 (fr) * 1997-09-17 1999-03-25 Genentech, Inc. Traitement d'affections liees aux fonctions immunitaires et compositions correspondantes
US6410708B1 (en) 1997-11-21 2002-06-25 Genentech, Inc. Nucleic acids encoding A-33 related antigen polypeptides
CA2382506A1 (fr) * 1997-09-17 1999-03-25 Genentech, Inc. Nouveaux polypeptides et acides nucleiques codant le polypeptide pro 293, utiles pour traiter les troubles du pancreas
US7282565B2 (en) 1998-03-20 2007-10-16 Genentech, Inc. PRO362 polypeptides
US7273726B2 (en) 1997-11-21 2007-09-25 Genentech, Inc. Compounds, compositions and methods for the treatment of diseases characterized by A-33 related antigens
US8088386B2 (en) 1998-03-20 2012-01-03 Genentech, Inc. Treatment of complement-associated disorders
PT1481989E (pt) * 1997-11-21 2008-08-08 Genentech Inc Antigénios relacionados com a-33 e suas utilizações farmacológicas
US8007798B2 (en) 1997-11-21 2011-08-30 Genentech, Inc. Treatment of complement-associated disorders
AU2005202246B2 (en) * 1999-03-11 2007-12-20 Merck Serono Sa Vascular adhesion molecules and modulation of their function
AU2008201101B2 (en) * 1999-03-11 2011-01-20 Merck Serono Sa Vascular adhesion molecules and modulation of their function
EE05497B1 (et) * 1999-03-11 2011-12-15 Rmf Dictagene S.A. Polüpeptiid, lahustuv CRAM-1 polüpeptiid, polünukleotiid ja antikeha
EP1206479A1 (fr) * 1999-08-24 2002-05-22 Texas Biotechnology Corporation Polynucleotide codant une proteine d'adhesion jonctionnelle humaine (jam-2)
WO2002012285A2 (fr) * 2000-08-10 2002-02-14 Board Of Regents, The University Of Texas System Suppresseur de tumeur car-1
US6753418B2 (en) * 2000-10-05 2004-06-22 Case Western Reserve University Suppressors of human breast cancer cell growth
US8007797B2 (en) 2006-09-28 2011-08-30 Merck Serono S.A. Junctional adhesion molecule-C (JAM-C) binding compounds and methods of their use
BRPI0912003A2 (pt) 2008-05-06 2016-07-12 Genentech Inc afinidade de variantes de crig maturadas

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
WO1997007198A2 (fr) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Sequences d'adn et proteines secretees codees par celles-ci

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5536637A (en) * 1993-04-07 1996-07-16 Genetics Institute, Inc. Method of screening for cDNA encoding novel secreted mammalian proteins in yeast
WO1997007198A2 (fr) * 1995-08-11 1997-02-27 Genetics Institute, Inc. Sequences d'adn et proteines secretees codees par celles-ci

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
Database EMBL, entry HS074341, Accession number N35074, 19 January 1996 100% identity with Seq.ID:1 nt.1702-2170 reverse orientation *
Database EMBL, entry HS081268, Accession number N21081, 8 January 1996 96% identity with Seq.ID:1 nt.636-1097 *
Database EMBL, entry HS814281, Accession number N43814, 9 February 1996 97% identity with Seq.ID:1 nt.1338-1659 *
Database EMBL, entry HSAA99506, Accession number AA099506, 29 October 1996 98% identity with Seq.ID:1 nt.546-927 *
Database EMBL, entry MM23812, Accession number W34238, 16 May 1996 92% identity with Seq.ID:1 nt.1323-1740 *
Database EMBL, entry MM35910, Accession number W29359, 10 May 1996 85% identity with Seq.ID:1 nt.112-506 *

Also Published As

Publication number Publication date
WO1998042739A2 (fr) 1998-10-01
JP2002503955A (ja) 2002-02-05
AU6578398A (en) 1998-10-20
CA2283631A1 (fr) 1998-10-01
EP0970111A2 (fr) 2000-01-12

Similar Documents

Publication Publication Date Title
WO1998007859A3 (fr) Proteines secretees et polynucleotides codant lesdites proteines
WO1998017687A3 (fr) Proteines secretees et polynucleotides codant ces proteines
WO1999057132A8 (fr) Proteines secretees et polynucleotides codant pour celles-ci
WO1997007198A3 (fr) Sequences d'adn et proteines secretees codees par celles-ci
WO1998033916A3 (fr) Proteines secretees et polynucleotides codant celles-ci
WO1998042741A3 (fr) Proteines secretees et polynucleotides les codant
WO1998042739A3 (fr) Proteines secretees et polynucleotides les codant
WO1998004693A3 (fr) Proteines secretees et polynucleotides les codant
WO1998055614A3 (fr) Proteines secretees et polynucleotides codant ces proteines
WO1998040486A3 (fr) Proteines secretees et polynucleotides les codant
WO1998027205A3 (fr) Proteines secretees et polynucleotides codant pour lesdites proteines
WO1998005776A3 (fr) Proteines secretees et polynucleotides codant ces proteines
WO1999058642A3 (fr) Proteines secretees et polynucleotides codant pour ces dernieres
WO1998046757A3 (fr) Proteines secretees et polynucleotides codant ces proteines
WO1998032853A3 (fr) Proteines secretees et polynucleotides les codant
WO1998037094A3 (fr) Proteines secretees et polynucleotides les codant
AU4189999A (en) Secreted proteins and polynucleotides encoding them
AU6553898A (en) Human secreted protein, ba3.1, and polynucleotides encoding same
WO1998040404A3 (fr) Proteines secretees et polynucleotides codant ces dernieres
WO1998056909A3 (fr) Proteines secretees et polynucleotides les codant
WO1998030589A3 (fr) Proteines secretees et polynucleotides les codant
WO1998041539A3 (fr) Proteines secretees et polynucleotides les codant
WO1998021332A3 (fr) Proteines secretes et polynucleotides les codant
WO1998030696A8 (fr) Proteines secretees et polynucleotides les codant
WO1998038209A3 (fr) Proteines secretees et polynucleotides codant pour celles-ci

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE GH GM GW HU ID IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT UA UG UZ VN YU ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW SD SZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
ENP Entry into the national phase

Ref document number: 2283631

Country of ref document: CA

Ref country code: CA

Ref document number: 2283631

Kind code of ref document: A

Format of ref document f/p: F

ENP Entry into the national phase

Ref country code: JP

Ref document number: 1998 545874

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1998911944

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1998911944

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

WWW Wipo information: withdrawn in national office

Ref document number: 1998911944

Country of ref document: EP